Tokyo, Japan

Hironori Kubota



Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 32(Granted Patents)


Location History:

  • Chiyoda-ku, JP (2006)
  • Tokyo, JP (2006 - 2019)

Company Filing History:


Years Active: 2006-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Hironori Kubota: Innovator in Pharmaceutical Formulations

Introduction

Hironori Kubota is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical formulations, holding a total of 4 patents. His work focuses on innovative dosage forms that enhance the delivery and efficacy of active ingredients.

Latest Patents

Among his latest patents, Kubota has developed millicapsule formulations comprising polyunsaturated free fatty acids. These capsular dosage forms contain compositions that are designed for improved absorption and effectiveness. In particular, his patents detail unit dosage forms that include a plurality of millicapsules filled with a polyunsaturated free fatty acid in its free acid form. Additionally, he has created a water-soluble composition that includes coenzyme Q and various esters, which demonstrates superior resistance to acid, salt, and heat. This composition is particularly beneficial for blending into medicines, foods, beverages, and cosmetics.

Career Highlights

Hironori Kubota has worked with prominent companies in the pharmaceutical industry, including Nisshin Pharma Inc. and Freund Industrial Co., Ltd. His experience in these organizations has allowed him to refine his expertise in drug formulation and delivery systems.

Collaborations

Throughout his career, Kubota has collaborated with esteemed colleagues such as Tsuyoshi Minemura and Shigeo Takagi. These partnerships have contributed to the advancement of his innovative work in the field.

Conclusion

Hironori Kubota's contributions to pharmaceutical formulations highlight his role as a leading inventor in the industry. His patents reflect a commitment to enhancing drug delivery systems, which can significantly impact patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…